Division of Cancer Biology
Patient Derived Models of Cancer Consortium
Annual Meeting 2020
Agenda
November 4-5, 2020 (All time listed as EDT)
Wednesday, November 4, 12:00 p.m. – 5:00 p.m. ET
12:00 – 12:10 p.m. |
Welcome Dan Gallahan |
12:10 -12:20 p.m. |
Introduction of CSBC |
12:20 – 1:00 p.m. |
Keynote Speaker (30 min), questions (10 min) |
1:00 – 1:40 p.m. |
Session 1: Clinical translation |
1:00 -1:20 p.m. |
Epigenetic Reprogramming of Colon Cancer Models |
1:20 -1:40 p.m. |
Co-Clinical Patient-derived Models and Personalized Medicine for Breast cancer |
1:40 – 2:00 p.m. |
Group Discussion – Session 1 |
2:00 – 2:30 p.m. |
Break |
2:30 - 3:30 p.m. |
Mini Talks-Poster Session (1 hour) |
3:30 – 4:10 p.m. |
Session 2: Intra-tumor heterogeneity |
3:30 – 3:50 p.m. |
In situ Human Pancreatic Cancer Xenograft Models |
3:50 – 4:10 p.m. |
Steady-state Metabolic Profiling of Renal Cell Carcinoma Patient-derived Xenografts and Derived Tissue Slice Cultures |
4:10 - 4:30 p.m. |
Group Discussion – Session 2 |
4:30 – 5:00 p.m. |
Virtual social event |
Thursday, November 5, 12:00 p.m. – 4:00 p.m. ET
12:00 -12:40 p.m. |
Session 3: Emerging technology |
12:00 – 12:20 p.m. |
Identifying Glioblastoma Multiform (GBM) Subytpes Across Heterogeneous Transcriptome Profiling Data Sets with Robust and Interpretable Gene Signatures |
12:20 – 12:40 p.m. |
KCNA1 is Regulated by a Novel Set of miRNAs to Drive Pediatric Glioblastoma Invasion |
12:40 – 1:00 p.m. |
Group Discussion – Session 3 |
1:00 – 1:40 p.m. |
Session 4: Tumor Systems Biology |
1:00 – 1:20 p.m. |
Leveraging Patient-Derived Models to Study Mechanisms of Tolerance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer |
1:20 – 1:40 p.m. |
The MDA PCa PDX series, a Dynamic Resource that Captures the Molecular Landscape of PCa and is a Platform for Discovery |
1:40 – 2:00 p.m. |
Group Discussion – Session 4 |
2:00 – 2:10 p.m. |
Break (10 min) |
2:10 – 3:10 p.m. |
Mini Talks-Poster session (1 hour) |
3:10 – 3:20 p.m. |
Break (10 min) – time to discuss and score posters for the awards |
3:20 – 4:00 p.m. |
Session 5: The tumor microenvironment |
3:20 – 3:40 p.m. |
Patient-derived Modeling of Pancreatic Cancer Tumor and Stromal Heterogeneity |
3:40 – 4:00 p.m. |
Lymph Protects Metastasizing Melanoma Cells from Ferroptosis |
4:00 – 4:20 p.m. |
Group Discussion – Session 5 |
4:20 – 4:30 p.m. |
Concluding remarks and poster awards |